Prelude Capital Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,800
Closed -$28.6K 1334
2024
Q3
$28.6K Sell
16,800
-2,286
-12% -$3.89K ﹤0.01% 1127
2024
Q2
$26.1K Buy
19,086
+1,236
+7% +$1.69K ﹤0.01% 1075
2024
Q1
$66.9K Sell
17,850
-2,309
-11% -$8.66K ﹤0.01% 1121
2023
Q4
$198K Buy
+20,159
New +$198K 0.01% 817
2023
Q2
Sell
-21,677
Closed -$251K 1191
2023
Q1
$251K Buy
+21,677
New +$251K 0.02% 656
2022
Q4
Sell
-88,851
Closed -$516K 1402
2022
Q3
$516K Buy
+88,851
New +$516K 0.02% 621
2021
Q4
Sell
-22,000
Closed -$562K 1829
2021
Q3
$562K Sell
22,000
-41,300
-65% -$1.06M 0.01% 612
2021
Q2
$2.21M Buy
63,300
+3,690
+6% +$129K 0.07% 195
2021
Q1
$1.99M Buy
59,610
+37,610
+171% +$1.25M 0.05% 184
2020
Q4
$571K Buy
22,000
+2,500
+13% +$64.9K 0.01% 341
2020
Q3
$192K Sell
19,500
-2,500
-11% -$24.6K 0.01% 512
2020
Q2
$76K Buy
+22,000
New +$76K ﹤0.01% 717
2020
Q1
Sell
-162,525
Closed -$835K 1391
2019
Q4
$835K Sell
162,525
-26,669
-14% -$137K 0.03% 226
2019
Q3
$976K Buy
189,194
+37,635
+25% +$194K 0.04% 165
2019
Q2
$917K Buy
+151,559
New +$917K 0.05% 190
2019
Q1
Sell
-56,782
Closed -$420K 1634
2018
Q4
$420K Buy
56,782
+56,053
+7,689% +$415K 0.03% 337
2018
Q3
$4K Buy
729
+29
+4% +$159 ﹤0.01% 1283
2018
Q2
$2K Buy
+700
New +$2K ﹤0.01% 1306
2017
Q3
Sell
-15,311
Closed -$55K 1696
2017
Q2
$55K Sell
15,311
-203
-1% -$729 0.01% 878
2017
Q1
$80K Buy
15,514
+15,373
+10,903% +$79.3K 0.01% 811
2016
Q4
$1K Buy
+141
New +$1K ﹤0.01% 1451
2016
Q2
Sell
-990
Closed -$8K 1623
2016
Q1
$8K Buy
+990
New +$8K ﹤0.01% 1104
2015
Q1
Sell
-3,256
Closed -$26K 1997
2014
Q4
$26K Sell
3,256
-1,474
-31% -$11.8K ﹤0.01% 1571
2014
Q3
$23K Buy
+4,730
New +$23K ﹤0.01% 1592